首页>投融资
Sherlock Biosciences
收并购
Sherlock Biosciences Inc operates as an engineering biology company. The Company develops a molecular diagnostics platform.In February 2023, Sense Biodetection Ltd was acquired by Sherlock Biosciences Inc.In June 2021, Sherlock Biosciences had Partnered with NorDx Laboratories.In March 2022, Sherlock Biosciences Inc announced it has raised $80 million in a Series B financing
基本信息
-
公司全称Sherlock Biosciences Inc
-
类型分子诊断产品开发商
-
产业领域医疗器械
-
公司人数15~50人
-
地址40 Guest Street 3Rd Floor BRIGHTON MASSACHUSETTS 02135; US; Telephone: +16176128209;
-
联系电话
-
邮箱partners@sherlock.bio
-
成立时间2019-02-01
投融资
-
2024-12-19收并购2500万美元Orasure Technologies
-
2022-03-08B轮8000万美元Catalio Capital ManagementGood VenturesIllumina VenturesNovalis LifeSciencesNorthpond VenturesAlbany Capital
-
2019-04-23A轮3100万美元Northpond VenturesOpen Philanthropy Project
-
2019-03-22未透露3500万美元未透露
- 加载更多
相关投融资企业
C轮
Francis Medical is a dynamic medical device company committed to developing urological cancer treatments that are tough on cancer yet gentle on patients.In September 2020, Coloplast announced that it has completed a USD 4m (DKK 25m) equity investment in Francis Medical
收并购
Gynesonics is a developer of transcervical, uterus-preserving, incision-free technologies for diagnostic and therapeutic applications (avoiding invasive surgical techniques of hysterectomy or myomectomy for symptomatic uterine fibroids). Products include the Sonata system which combines intrauterine ultrasound guidance with targeted radiofrequency ablation.In April 2023, the company closed a financing round of $25M
未公开
PBS Biotech 是一次性生物反应器系统的领先制造商。PBS 生物反应器利用专有的“Vertical-Wheel TM ”技术来支持剪切敏感的细胞治疗产品。PBS Biotech愿景是成为世界上同种异体细胞疗法的标准制造平台。
浙公网安备33011002015279
本网站未发布麻醉药品、精神药品、医疗用毒性药品、放射性药品、戒毒药品和医疗机构制剂的产品信息